Mycophenolate Sodium

Dutasteride is a triple 5α-reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone. It is used to treat benign prostatic hyperplasia. It increases the risk of erectile dysfunction and decreased sexual desire.

Dutasteride API is...

Gadobutrol is a gadolinium-based MRI contrast agent.
It is approved by NMPA.
US-DMF is available.

Gefitinib is a drug used for certain breast, lung and other cancers. 

It is in R&D stage.

Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has no to few central effects. A synthetic quaternary amine, it is available in oral and intravenous forms and as...

Indacaterol is an ultra-long-acting beta-adrenoceptor agonist. It is for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). It is delivered as an aerosol formulation through a dry powder inhaler. qq...

Iohexol is a kind of contrast agent.

Iohexol API is still in R&D stage.

Obeticholic acid is a semi-synthetic bile acid analogue which has the chemical structure 6α-ethyl-chenodeoxycholic acid. It is used as a drug to treat primary biliary cholangitis.

It is in R&D stage.

Parecoxib is a water-soluble and injectable prodrug of valdecoxib. 

It is in R&D stage.

Rolapitant is used for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.

It is in R&D stage.

Tolvaptan is a selective, competitive vasopressin receptor 2 antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).

Tolvapta...

Zinc Acetate is commonly used in chemical synthesis and as dietary supplements.

It is in R&D stage.

Zolmitriptan is a selective serotonin receptor agonist of the 1B and 1D subtypes. It is a triptan, used in the acute treatment of migraine attacks with or without aura and cluster headaches.

It is in R&D stage.

Hengrui Medicine is dedicated to research, developing, and promoting innovative medicine with high quality.